Chemosensitivity testing of human lung cancer cell lines using the MTT assay

J. Carmichael, J. B. Mitchell, W. G. DeGraff, J. Gamson, A. F. Gazdar, B. E. Johnson, E. Glatstein, J. D. Minna

Research output: Contribution to journalArticle

195 Citations (Scopus)

Abstract

Thirty human lung cancer cell lines were tested for chemosensitivity using the semi-automated, non-clonogenic MTT assay. The tumour cell lines came from three major categories of patients: untreated small cell lung cancer (SCLC); SCLC relapsing on chemotherapy; and non-SCLC predominantly from untreated patients. From these data IC50 values were derived for each drug in each cell line. While some inter-experimental variability was observed, the rank order of chemosensitivity of each cell line within this panel was significantly correlated between experiments. These results show that tumour cell lines derived from untreated small cell lung cancer patients were the most chemosensitive for adriamycin, melphalan, vincristine and VP16 compared to the other cell types. In addition, untreated SCLC was more sensitive than non-SCLC to BCNU and cis-platin, while vincristine was the only drug to which treated SCLC was more sensitive compared to the non-SCLC lines. In contrast, no significant differences between the lung cancer types were observed for vinblastine. Thus, this panel of lung cancer cells exhibited a drug sensitivity profile paralleling that observed in clinical practice. These results suggest that this lung cancer cell line panel in combination with a relatively simple but reproducible chemosensitivity assay, such as the MTT assay, has potential for the testing of drug combinations and evaluating new anti-cancer agents in vitro.

Original languageEnglish (US)
Pages (from-to)540-547
Number of pages8
JournalBritish Journal of Cancer
Volume57
Issue number6
StatePublished - 1988

Fingerprint

Small Cell Lung Carcinoma
Lung Neoplasms
Cell Line
Non-Small Cell Lung Carcinoma
Vincristine
Tumor Cell Line
Pharmaceutical Preparations
Carmustine
Melphalan
Vinblastine
Drug Combinations
Doxorubicin
Inhibitory Concentration 50
Drug Therapy
Neoplasms

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Carmichael, J., Mitchell, J. B., DeGraff, W. G., Gamson, J., Gazdar, A. F., Johnson, B. E., ... Minna, J. D. (1988). Chemosensitivity testing of human lung cancer cell lines using the MTT assay. British Journal of Cancer, 57(6), 540-547.

Chemosensitivity testing of human lung cancer cell lines using the MTT assay. / Carmichael, J.; Mitchell, J. B.; DeGraff, W. G.; Gamson, J.; Gazdar, A. F.; Johnson, B. E.; Glatstein, E.; Minna, J. D.

In: British Journal of Cancer, Vol. 57, No. 6, 1988, p. 540-547.

Research output: Contribution to journalArticle

Carmichael, J, Mitchell, JB, DeGraff, WG, Gamson, J, Gazdar, AF, Johnson, BE, Glatstein, E & Minna, JD 1988, 'Chemosensitivity testing of human lung cancer cell lines using the MTT assay', British Journal of Cancer, vol. 57, no. 6, pp. 540-547.
Carmichael J, Mitchell JB, DeGraff WG, Gamson J, Gazdar AF, Johnson BE et al. Chemosensitivity testing of human lung cancer cell lines using the MTT assay. British Journal of Cancer. 1988;57(6):540-547.
Carmichael, J. ; Mitchell, J. B. ; DeGraff, W. G. ; Gamson, J. ; Gazdar, A. F. ; Johnson, B. E. ; Glatstein, E. ; Minna, J. D. / Chemosensitivity testing of human lung cancer cell lines using the MTT assay. In: British Journal of Cancer. 1988 ; Vol. 57, No. 6. pp. 540-547.
@article{f11a42f3c2be47f5818e1da927dad30e,
title = "Chemosensitivity testing of human lung cancer cell lines using the MTT assay",
abstract = "Thirty human lung cancer cell lines were tested for chemosensitivity using the semi-automated, non-clonogenic MTT assay. The tumour cell lines came from three major categories of patients: untreated small cell lung cancer (SCLC); SCLC relapsing on chemotherapy; and non-SCLC predominantly from untreated patients. From these data IC50 values were derived for each drug in each cell line. While some inter-experimental variability was observed, the rank order of chemosensitivity of each cell line within this panel was significantly correlated between experiments. These results show that tumour cell lines derived from untreated small cell lung cancer patients were the most chemosensitive for adriamycin, melphalan, vincristine and VP16 compared to the other cell types. In addition, untreated SCLC was more sensitive than non-SCLC to BCNU and cis-platin, while vincristine was the only drug to which treated SCLC was more sensitive compared to the non-SCLC lines. In contrast, no significant differences between the lung cancer types were observed for vinblastine. Thus, this panel of lung cancer cells exhibited a drug sensitivity profile paralleling that observed in clinical practice. These results suggest that this lung cancer cell line panel in combination with a relatively simple but reproducible chemosensitivity assay, such as the MTT assay, has potential for the testing of drug combinations and evaluating new anti-cancer agents in vitro.",
author = "J. Carmichael and Mitchell, {J. B.} and DeGraff, {W. G.} and J. Gamson and Gazdar, {A. F.} and Johnson, {B. E.} and E. Glatstein and Minna, {J. D.}",
year = "1988",
language = "English (US)",
volume = "57",
pages = "540--547",
journal = "British Journal of Cancer",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Chemosensitivity testing of human lung cancer cell lines using the MTT assay

AU - Carmichael, J.

AU - Mitchell, J. B.

AU - DeGraff, W. G.

AU - Gamson, J.

AU - Gazdar, A. F.

AU - Johnson, B. E.

AU - Glatstein, E.

AU - Minna, J. D.

PY - 1988

Y1 - 1988

N2 - Thirty human lung cancer cell lines were tested for chemosensitivity using the semi-automated, non-clonogenic MTT assay. The tumour cell lines came from three major categories of patients: untreated small cell lung cancer (SCLC); SCLC relapsing on chemotherapy; and non-SCLC predominantly from untreated patients. From these data IC50 values were derived for each drug in each cell line. While some inter-experimental variability was observed, the rank order of chemosensitivity of each cell line within this panel was significantly correlated between experiments. These results show that tumour cell lines derived from untreated small cell lung cancer patients were the most chemosensitive for adriamycin, melphalan, vincristine and VP16 compared to the other cell types. In addition, untreated SCLC was more sensitive than non-SCLC to BCNU and cis-platin, while vincristine was the only drug to which treated SCLC was more sensitive compared to the non-SCLC lines. In contrast, no significant differences between the lung cancer types were observed for vinblastine. Thus, this panel of lung cancer cells exhibited a drug sensitivity profile paralleling that observed in clinical practice. These results suggest that this lung cancer cell line panel in combination with a relatively simple but reproducible chemosensitivity assay, such as the MTT assay, has potential for the testing of drug combinations and evaluating new anti-cancer agents in vitro.

AB - Thirty human lung cancer cell lines were tested for chemosensitivity using the semi-automated, non-clonogenic MTT assay. The tumour cell lines came from three major categories of patients: untreated small cell lung cancer (SCLC); SCLC relapsing on chemotherapy; and non-SCLC predominantly from untreated patients. From these data IC50 values were derived for each drug in each cell line. While some inter-experimental variability was observed, the rank order of chemosensitivity of each cell line within this panel was significantly correlated between experiments. These results show that tumour cell lines derived from untreated small cell lung cancer patients were the most chemosensitive for adriamycin, melphalan, vincristine and VP16 compared to the other cell types. In addition, untreated SCLC was more sensitive than non-SCLC to BCNU and cis-platin, while vincristine was the only drug to which treated SCLC was more sensitive compared to the non-SCLC lines. In contrast, no significant differences between the lung cancer types were observed for vinblastine. Thus, this panel of lung cancer cells exhibited a drug sensitivity profile paralleling that observed in clinical practice. These results suggest that this lung cancer cell line panel in combination with a relatively simple but reproducible chemosensitivity assay, such as the MTT assay, has potential for the testing of drug combinations and evaluating new anti-cancer agents in vitro.

UR - http://www.scopus.com/inward/record.url?scp=0023895289&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023895289&partnerID=8YFLogxK

M3 - Article

C2 - 2841961

AN - SCOPUS:0023895289

VL - 57

SP - 540

EP - 547

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 6

ER -